Cassie Moore, Ph.D

Preclinical Assessment of Cannabinoid-Based Medications for Treatment of Multidimensional Opiod Withdrawal

January 2024

Cassie Moore, PhD is an Assistant Professor in the Division of Behavioral Biology at the Johns Hopkins University School of Medicine. Her research uses animal models to explore the balance between potential benefits and consequences of cannabinoid-based medications. Recent projects have been focused on the treatment of opioid withdrawal by cannabinoids and novel compounds targeting the endocannabinoid system. Other ongoing projects in the lab are assessing the effects of vaped or orally administered cannabinoids (e.g., Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD)) and terpenes (e.g., alpha-pinene, limonene) on behaviors including reward, attention, and anxiety-like behavior.

Previous Webinars

Devan Kansagara, MD., MCR.

June 12th 1:00 PM MST

Systematically Testing the Evidence on Marijuana (STEM): Bridging the Science of Cannabis Health Effects and Clinical Practice

Devan Kansagara MD, MCR is a Professor of Medicine at Oregon Health and Science University. He practices and teaches primary care and hospital-based internal medicine in the VA Portland Health Care System. His work in […]

Read More »

Nolan Kane, PhD.

May 21, 2025 11:00 AM Mountain Time

Genetics, chemistry and the evolution of sex chromosomes in Cannabis

Dr. Nolan Kane is an associate professor in the ebio department at the university of Colorado, boulder. he uses genomic approaches to study adaptation to new environments, domestication of wild plants into valuable crops, and the formation of new species. his […]

Read More »

Dan Covey, PhD.

May 8, 2025, 1:00 PM

Effects of isolated cannabinoids and endocannabinoids on emotional behavior in rodents

Dr. Covey is currently an Assistant Professor at Lovelace Biomedical Research Institute (LBRI) in Albuquerque, New Mexico. He started this position in June 2020 after completing his PhD at Illinois State University and a postdoctoral fellowship at the University of Maryland […]

Read More »

Andrew Kesner, PhD

Preclinical modeling of spontaneous Δ-9-THC withdrawal symptoms in mice: sleep, dopamine, and behavioral maladaptations

April 10th, 1:00PM MST

Dr. Kesner is the Chief of the Unit on Motivation and Arousal at National Institute on Alcohol Abuse and Alcoholism (NIAAA). The mission of his lab is to use systems neuroscience approaches to understand how brain systems controlling motivated […]

Read More »

Roberta Paris, PhD.

Genetic, molecular and biochemical studies on the accumulation of bioactive compounds in Cannabis sativa L.

19 March, 2025, 11:00 AM  

Dr. Roberta Paris studied at the Alma Mater Studiorum, University of Bologna, where she obtained the PhD in Cellular and Molecular Biology in 2006. She is a permanent researcher at Council for Agricultural Research and Economic, Research […]

Read More »

Sarah D. Lichenstein, PhD.

Neural mechanisms of risk for problem-level cannabis use among emerging adults

Dr. Lichenstein is a licensed clinical psychologist, an Assistant Professor of Psychiatry, and Assistant Director of the Yale Imaging and Psychopharmacology Lab at Yale School of Medicine. She received her BA in Psychology from Bard College (2008), and her PhD in Clinical Psychology from the […]

Read More »

Institute of Cannabis Research

The Institute of Cannabis Research is the state of Colorado’s official cannabis research institute and is here to provide our citizenry with unbiased and objective scientific facts about cannabis biology, chemistry, health effects, economic impacts, and more.

 

Quick LInks

Follow Us On

Facebook Youtube Linkedin